Abstract
The biocompatibility/cytotoxicity of materials intended for biomedical applications are always of utter importance (Danoux et al. in Acta Mater 17:1–15, 2015 [1], Yan et al. in Acta Biomater 12:227–241, 2015 [2]) Although the main objective of such testing is mostly related to assessment of the respective material safety and efficiency, functional testing of materials in relation to their targeted use is also needed to be considered. The main objective of the approach towards such testing is, therefore, not only related to the assessment of the specific materials’ biocompatibility with desired cells, but also the execution of the test as similar to the physiological application as possible (Naranda et al. in Sci Rep 6:28695, 2016 [3], Finšgar et al. in Sci Rep 6:26653, 2016 [4]). Related to this, the effect of possibly released toxic degradation products that could hinder cell growth can be determined, as well as possible local overdoses of respective drugs, which are often part of tested formulations, could be assessed, since these could also potentially harm the growing cells (Finšgar et al. in Sci Rep 6:26653, 2016[4]). Another related testing approach is to determine the respective formulation influence on the cell growth in comparison with different control samples (Naranda et al. in Sci Rep 6:28695, 2016 [3], Gradisnik et al. in Global Spine J 6:WST014, 2016 [5], Velnar et al. in Global Spine J 6:WST019, 2016 [6]). The following chapter will, therefore, be composed of two main parts. The first will review briefly some of the most used testing approaches in general (mostly according to the related ISO Standard—ISO 10993), while the second part will review and describe some of possible modifications of such standard approaches to get the best possible overview of the respective materials’ safety and efficiency for a specific purpose.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Danoux CBSS, Bassett DC, Othman Z, Rodrigues AI, Reis RL, Barralet JE, et al. Elucidating the individual effects of calcium and phosphate ions on hMSCs by using composite materials. Acta Mater. 2015;17:1–15.
Yan L-P, Silva-Correia J, Oliveira MB, Vilela C, Pereira H, Sousa RA, et al. Bilayered silk/silk-nanoCaP scaffolds for osteochondral tissue engineering: in vitro and in vivo assessment of biological performance. Acta Biomater. 2015;12:227–41.
Naranda J, Susec M, Maver U, Gradisnik L, Gorenjak M, Vukasovic A, et al. Polyester type polyHIPE scaffolds with an interconnected porous structure for cartilage regeneration. Sci Rep. 2016;6:28695.
Finšgar M, Uzunalić AP, Stergar J, Gradišnik L, Maver U. Novel chitosan/diclofenac coatings on medical grade stainless steel for hip replacement applications. Sci Rep. 2016;6:26653.
Gradisnik L, Maver U, Bunc G, Velnar T. The effect of iodixanol on human intervertebral disc cells in vitro. Global Spine J. 2016;06(S 01):WST014.
Velnar T, Bunc G, Maver U, Gradisnik L. The intervertebral disc functional cell models: a new revolution for in vitro toxicology testing. Global Spine J. 2016;06(S 01):WST019.
International Organization for S. Biological evaluation of medical devices. Évaluation biologique des dispositifs médicaux. Partie 5, Essais concernant la cytotoxicité in vitro. Part 5. Genève, Switzerland: International Organization for Standardization; 1999.
Johnson HJ, Northup SJ, Seagraves PA, Atallah M, Garvin PJ, Lin L, et al. Biocompatibility test procedures for materials evaluation in vitro. II. Objective methods of toxicity assessment. J Biomed Mater Res. 1985;19(5):489–508.
Li W, Zhou J, Xu Y. Study of the in vitro cytotoxicity testing of medical devices. Biomed Rep. 2015;3(5):617–20.
Cao T, Saw TY, Heng BC, Liu H, Yap AUJ, Ng ML. Comparison of different test models for the assessment of cytotoxicity of composite resins. J Appl Toxicol. 2005;25(2):101–8.
Hanks CT, Wataha JC, Sun Z. In vitro models of biocompatibility: a review. Dent Mater. 1996;12(3):186–93.
Pizzoferrato A, Ciapetti G, Stea S, Cenni E, Arciola CR, Granchi D, et al. Cell culture methods for testing biocompatibility. Clin Mater. 1994;15(3):173–90.
Vanden Berghe T, Grootjans S, Goossens V, Dondelinger Y, Krysko DV, Takahashi N, et al. Determination of apoptotic and necrotic cell death in vitro and in vivo. Methods. 2013;61(2):117–29.
Hartley JM, Spanswick VJ, Hartley JA. Measurement of DNA damage in individual cells using the single cell gel electrophoresis (Comet) assay. Methods Mol Biol. 2011;731:309–20.
Jonas E, Dwenger A, Lueken B, Boehme U. Simultaneous measurement of endothelial cell damage, elastase release and chemiluminescence response during interaction between polymorphonuclear leukocytes and endothelial cells. J Biolumin Chemilumin. 1991;6(1):19–27.
Son S, Tzur A, Weng Y, Jorgensen P, Kim J, Kirschner MW, et al. Direct observation of mammalian cell growth and size regulation. Nat Methods. 2012;9(9):910–2.
Stelling J, Klamt S, Bettenbrock K, Schuster S, Gilles ED. Metabolic network structure determines key aspects of functionality and regulation. Nature. 2002;420(6912):190–3.
Wang K, Shindoh H, Inoue T, Horii I. Advantages of in vitro cytotoxicity testing by using primary rat hepatocytes in comparison with established cell lines. J Toxicol Sci. 2002;27(3):229–37.
Farwell DG, Shera KA, Koop JI, Bonnet GA, Matthews CP, Reuther GW, et al. Genetic and epigenetic changes in human epithelial cells immortalized by telomerase. Am J Pathol. 2000;156(5):1537–47.
Gradisnik L, Trapecar M, Rupnik MS, Velnar T. HUIEC, Human intestinal epithelial cell line with differentiated properties: process of isolation and characterisation. Wien Klin Wochenschr. 2015;127(Suppl 5):S204–9.
Uklejewski R, Rogala P, Winiecki M, Kedzia A, Ruszkowski P. Preliminary results of implantation in animal model and osteoblast culture evaluation of prototypes of biomimetic multispiked connecting scaffold for noncemented stemless resurfacing hip arthroplasty endoprostheses. BioMed Res Int. 2013.
Santillan G, Morelli S, Katz S, Mondelo N, Boland R, Puche R, et al. Action of the novel bisphosphonate lidadronate in animal models and osteoblast-like cells. Bone. 2004;34:S69–70.
Ma R, Tang S, Tan H, Lin W, Wang Y, Wei J, et al. Preparation, characterization, and in vitro osteoblast functions of a nano-hydroxyapatite/polyetheretherketone biocomposite as orthopedic implant material. Int J Nanomed. 2014;9:3949–61.
Gyorgyey A, Ungvari K, Kecskemeti G, Kopniczky J, Hopp B, Oszko A, et al. Attachment and proliferation of human osteoblast-like cells (MG-63) on laser-ablated titanium implant material. Mater Sci Eng C, Mater Biol Appl. 2013;33(7):4251–9.
Czekanska EM, Stoddart MJ, Ralphs JR, Richards RG, Hayes JS. A phenotypic comparison of osteoblast cell lines versus human primary osteoblasts for biomaterials testing. J Biomed Mater Res, Part A. 2014;102(8):2636–43.
Narandaa J, Gradišnik L, Gorenjak M, Vogrin M, Maver U. Isolation and characterization of human articular chondrocytes from surgical waste after total knee arthroplasty (TKA). PeerJ. 2017 (In press).
Dreifke MB, Jayasuriya AA, Jayasuriya AC. Current wound healing procedures and potential care. Mater Sci Eng, C. 2015;48:651–62.
Maver T, Gradišnik L, Kurečič M, Hribernik S, Smrke DM, Maver U, et al. Layering of different materials to achieve optimal conditions for treatment of painful wounds. Int J Pharm. 2017;529(1–2):576–88.
Stergar J, Ban I, Gradišnik L, Bele M, Mohan T, Maver U. Advanced biocompatible composite thin films with potential application in wound care and skin cancer treatment. Chem Mater. 2017 (In press).
Cory G. Scratch-wound assay. Methods Mol Biol. 2011;769:25–30.
Kim TY, Jang IH, Han DY, Lee WG. Quantitative image analysis of the shape and size of circular wound sites generated by vertically stamped scratches. Micron. 2017.
Planz V, Wang J, Windbergs M. Establishment of a cell-based wound healing assay for bio-relevant testing of wound therapeutics. J Pharmacol Toxicol Methods. 2017.
Maver T, Hribernik S, Mohan T, Smrke DM, Maver U, Stana-Kleinschek K. Functional wound dressing materials with highly tunable drug release properties. RSC Adv. 2015;5(95):77873–84.
Banche G, Prato M, Magnetto C, Allizond V, Giribaldi G, Argenziano M, et al. Antimicrobial chitosan nanodroplets: new insights for ultrasound-mediated adjuvant treatment of skin infection. Future Microbiol. 2015;10:929–39.
Park SC, Nam JP, Kim JH, Kim YM, Nah JW, Jang MK. Antimicrobial action of water-soluble beta-chitosan against clinical multi-drug resistant bacteria. Int J Mol Sci. 2015;16(4):7995–8007.
Silva JM, Duarte ARC, Custódio CA, Sher P, Neto AI, Pinho ACM, et al. Nanostructured hollow tubes based on chitosan and alginate multilayers. Adv Healthc Mater. 2014;3(3):433–40.
Gašparič P, Kurečič M, Maver U, Gradišnik L, Hribernik S, Kleinschek KS, et al. Novel polysaccharide/hydroxyapatite nanofibrous composite for bone tissue engineering. Carbohydr Polym. 2017 (In press).
Weinberg GL. Treatment of local anesthetic systemic toxicity (LAST). Reg Anesth Pain Med. 2010;35(2):188–93.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2018 The Author(s)
About this chapter
Cite this chapter
Maver, T., Maver, U., Pivec, T., Kurečič, M., Persin, Z., Stana Kleinschek, K. (2018). Safety and Efficiency Testing. In: Bioactive Polysaccharide Materials for Modern Wound Healing. SpringerBriefs in Molecular Science(). Springer, Cham. https://doi.org/10.1007/978-3-319-89608-3_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-89608-3_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-89607-6
Online ISBN: 978-3-319-89608-3
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)